New analysis adds to growing body of evidence in support of the use of sotagliflozin, an investigational dual SGLT1 and SGLT2 inhibitor, in the treatment of heart failureĀ
Data presented at the Heart Failure Society of America annual scientific meetingNew analysis adds to growing body of evidence in support of the use of.
New Analysis of SOLOIST-WHF Trial Underscores Sotagliflozin s Effect on Reducing Recurrent Heart Failure Events streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
New Analysis of SOLOIST-WHF Trial Underscores Sotagliflozin s Effect on Reducing Recurrent Heart Failure Events forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.